WO2008123128A1 - アディポネクチン産生促進剤 - Google Patents

アディポネクチン産生促進剤 Download PDF

Info

Publication number
WO2008123128A1
WO2008123128A1 PCT/JP2008/055238 JP2008055238W WO2008123128A1 WO 2008123128 A1 WO2008123128 A1 WO 2008123128A1 JP 2008055238 W JP2008055238 W JP 2008055238W WO 2008123128 A1 WO2008123128 A1 WO 2008123128A1
Authority
WO
WIPO (PCT)
Prior art keywords
enhancer
beverage
food
adiponectin production
pharmaceutical composition
Prior art date
Application number
PCT/JP2008/055238
Other languages
English (en)
French (fr)
Inventor
Norihisa Kato
Kazunobu Tokunaga
Kazuhisa Tsujimoto
Hideyuki Yamada
Original Assignee
Seiren Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seiren Kabushiki Kaisha filed Critical Seiren Kabushiki Kaisha
Priority to US12/450,286 priority Critical patent/US8722614B2/en
Priority to EP08722602A priority patent/EP2127663A4/en
Publication of WO2008123128A1 publication Critical patent/WO2008123128A1/ja

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • A23L2/66Proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

 本発明は、セリシンを有効成分として含んでなるアディポネクチン産生促進剤、およびそれを含む医薬および飲食品に関する。これらは、肥満に伴う動脈硬化、脂肪肝、糖尿病などのような、血中のアディポネクチン濃度の低下に起因する各種疾病の予防または改善に有効である。本発明よる促進剤、医薬組成物、および飲食品は、アディポネクチンの産生促進効果に優れ、かつ安全性が高く、各種の医薬や飲食品に幅広く応用が期待できる。
PCT/JP2008/055238 2007-03-23 2008-03-21 アディポネクチン産生促進剤 WO2008123128A1 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12/450,286 US8722614B2 (en) 2007-03-23 2008-03-21 Adiponectin production enhancer
EP08722602A EP2127663A4 (en) 2007-03-23 2008-03-21 ADIPONECTIN PRODUCTION PROMOTER

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007077131A JP2010018522A (ja) 2007-03-23 2007-03-23 アディポネクチン産生促進剤
JP2007-077131 2007-03-23

Publications (1)

Publication Number Publication Date
WO2008123128A1 true WO2008123128A1 (ja) 2008-10-16

Family

ID=39830625

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/055238 WO2008123128A1 (ja) 2007-03-23 2008-03-21 アディポネクチン産生促進剤

Country Status (4)

Country Link
US (1) US8722614B2 (ja)
EP (1) EP2127663A4 (ja)
JP (1) JP2010018522A (ja)
WO (1) WO2008123128A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010180149A (ja) * 2009-02-04 2010-08-19 Lintec Corp 嚥下補助剤

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101213825B1 (ko) 2010-07-16 2012-12-18 서울대학교산학협력단 세린을 유효성분으로 함유하는 지방간 질환의 예방 및 치료용 조성물
US20140037762A1 (en) * 2011-02-14 2014-02-06 Toshinori ITOU Adiponectin production promoter, and medicinal composition, food, drink and feed containing adiponectin production promoter
US9138455B2 (en) * 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9668999B2 (en) * 2014-04-23 2017-06-06 Semi Labs Limited Method for the treatment of hypercholesterolemia
WO2020141778A1 (ko) * 2018-12-31 2020-07-09 (주)엔아이앤팜 세리신을 포함하는 지방간 치료, 예방, 또는 완화용 조성물 및 상기 조성물의 제조 방법
KR20200083247A (ko) * 2018-12-31 2020-07-08 (주) 엔아이앤팜 세리신을 포함하는 지방간 치료, 예방, 또는 완화용 조성물 및 상기 조성물의 제조 방법
JP2021029143A (ja) * 2019-08-20 2021-03-01 オリザ油化株式会社 糖化抑制剤

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01256351A (ja) * 1988-04-01 1989-10-12 Terumo Corp 絹蛋白質を用いた食品およびその製造方法
JPH10140154A (ja) * 1996-11-08 1998-05-26 Seiren Co Ltd 抗酸化剤
JPH10265403A (ja) * 1997-03-24 1998-10-06 Seiren Co Ltd チロシナーゼ活性阻害剤
JP2000184868A (ja) * 1998-12-21 2000-07-04 Seiren Co Ltd 飲食品用水
JP2000256210A (ja) 1999-03-04 2000-09-19 Seiren Co Ltd 大腸ガン予防剤
JP2000312568A (ja) 1999-03-04 2000-11-14 Seiren Co Ltd 難消化性飲食品添加物及び健康補助剤
JP2001354584A (ja) * 2000-06-14 2001-12-25 Aioi Hakko:Kk 皮膚癌予防剤
JP2002128691A (ja) 2000-10-24 2002-05-09 National Institute Of Agrobiological Sciences セリシン含有素材、その製造方法およびその使用方法
JP2003231610A (ja) * 2002-02-05 2003-08-19 Mikimoto Pharmaceut Co Ltd 乳化組成物
JP2004018648A (ja) * 2002-06-14 2004-01-22 Seiren Co Ltd 抗酸化剤
JP2004244371A (ja) * 2003-02-14 2004-09-02 Kenji Nakamura 保湿組成物及びその製造方法
JP2006056836A (ja) 2004-08-20 2006-03-02 Taiyo Kagaku Co Ltd 脂肪組織特異分泌蛋白産生増強組成物
JP2006232787A (ja) * 2005-02-28 2006-09-07 Seiren Co Ltd 水溶性シルクタンパク質を含有する含水組成物
JP2007031302A (ja) 2005-07-25 2007-02-08 Noevir Co Ltd アディポネクチン産生促進剤、及び代謝異常症候群予防剤
JP2007077131A (ja) 2005-09-15 2007-03-29 Shigeharu Kaiho にがりを使用した歯磨き液の製造法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100478928B1 (ko) 1996-11-08 2005-08-18 세이렌가부시끼가이샤 세리신또는세리신가수분해물을유효성분으로하는비의약용항산화제,화장품,식품변색방지제,음식물,심근경색치료제,동맥경화치료제,당뇨병치료제,암치료제,또는뇌줄중치료제
CN1168493C (zh) 1999-03-04 2004-09-29 精炼株式会社 功能性口服剂
GB0213612D0 (en) * 2002-06-13 2002-07-24 Novartis Nutrition Ag Organic compounds
US20060128797A1 (en) * 2004-12-15 2006-06-15 Yanming Wang Method and composition for resuscitation

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01256351A (ja) * 1988-04-01 1989-10-12 Terumo Corp 絹蛋白質を用いた食品およびその製造方法
JPH10140154A (ja) * 1996-11-08 1998-05-26 Seiren Co Ltd 抗酸化剤
JPH10265403A (ja) * 1997-03-24 1998-10-06 Seiren Co Ltd チロシナーゼ活性阻害剤
JP2000184868A (ja) * 1998-12-21 2000-07-04 Seiren Co Ltd 飲食品用水
JP2000256210A (ja) 1999-03-04 2000-09-19 Seiren Co Ltd 大腸ガン予防剤
JP2000312568A (ja) 1999-03-04 2000-11-14 Seiren Co Ltd 難消化性飲食品添加物及び健康補助剤
JP2001354584A (ja) * 2000-06-14 2001-12-25 Aioi Hakko:Kk 皮膚癌予防剤
JP2002128691A (ja) 2000-10-24 2002-05-09 National Institute Of Agrobiological Sciences セリシン含有素材、その製造方法およびその使用方法
JP2003231610A (ja) * 2002-02-05 2003-08-19 Mikimoto Pharmaceut Co Ltd 乳化組成物
JP2004018648A (ja) * 2002-06-14 2004-01-22 Seiren Co Ltd 抗酸化剤
JP2004244371A (ja) * 2003-02-14 2004-09-02 Kenji Nakamura 保湿組成物及びその製造方法
JP2006056836A (ja) 2004-08-20 2006-03-02 Taiyo Kagaku Co Ltd 脂肪組織特異分泌蛋白産生増強組成物
JP2006232787A (ja) * 2005-02-28 2006-09-07 Seiren Co Ltd 水溶性シルクタンパク質を含有する含水組成物
JP2007031302A (ja) 2005-07-25 2007-02-08 Noevir Co Ltd アディポネクチン産生促進剤、及び代謝異常症候群予防剤
JP2007077131A (ja) 2005-09-15 2007-03-29 Shigeharu Kaiho にがりを使用した歯磨き液の製造法

Non-Patent Citations (17)

* Cited by examiner, † Cited by third party
Title
"Seikagaku Jiten", KABUSHIKI KAISHA TOKYO KAGAKU DOJIN, vol. 3RD ED., 20 November 1998 (1998-11-20), pages 785, XP003021995 *
ARITA, Y. ET AL., BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 257, 1999, pages 79 - 83
FOLCH ET AL.: "A simple method for the isolation and purification of total lipids from animal tissues", J BIOL. CHEM., vol. 226, 1957, pages 497 - 509
K. YAGI, BIOCHEM. MED., vol. 15, 1976, pages 212 - 216
KAKEI S. ET AL.: "Kinu Tanpakushitsu Sericin no Shishitsu Taisha Kaizen Sayo", THE 61ST JAPANESE SOCIETY OF NUTRITION AND FOOD SCIENCE TAIKAI KOEN YOSHISHU, 20 April 2007 (2007-04-20), pages 193, XP003021992 *
KURIOKA S. ET AL.: "Shoto Fukago no Kettochi ni Oyobosu Sasamayu Nessui Chushutsubutsu no Eikyo", NIPPON SILK GAKKAISHI, no. 15, 1 December 2006 (2006-12-01), pages 98 - 99, XP003021993 *
MAEDA N. ET AL., MOLECULAR MEDICINE, vol. 42, no. 1, 2005, pages 11 - 21
MAEDA N. ET AL.: "Adiponectin", MOLECULAR MEDICINE, vol. 42, no. 1, 2005, pages 11 - 21 *
MAEDA N. ET AL.: "PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein", DIABETES, vol. 50, September 2001 (2001-09-01), pages 2094 - 2099, XP002977678 *
MINAGAWA H. ET AL.: "Suiyosei Sericin no Shokasei Oyobi Ketchu Cholesterol-chi ni Oyobosu Eikyo", THE 57TH JAPANES SOCIETY OF NUTRITION AND FOOD SCIENCE TAIKAI KOEN YOSHISHU, 1 April 2003 (2003-04-01), pages 277, XP003021994 *
NAGASAWA ET AL., HORM. MERAB. RES., vol. 34, 2002, pages 635 - 639
NISHIDA K. ET AL.: "Ko-TNF alpha Kotai wa Ensho Seigyo Jotai ni Kakawarazu Adiponectin o Zoka saseru", FOLIA ENDOCRINOLOGICA JAPONICA, vol. 82, no. 1, 20 April 2006 (2006-04-20), pages 124, XP008113881 *
NOZAWA K. ET AL.: "Kinu Tanpakushitsu Sericin no Ketto Teika Sayo", JAPAN SOCIETY FOR BIOSCIENCE, BIOTECHNOLOGY, AND AGROCHEMISTRY 2003 NENDO (HEISEI 15 NENDO) TAIKAI KOEN YOSHISHU, 5 March 2003 (2003-03-05), pages 142, XP008133936 *
OUCHI, N. ET AL., CIRCULATION, vol. 100, 1999, pages 2473 - 2476
See also references of EP2127663A4
TADOKOR T. ET AL.: "Shokuhin Miriyo Shigen to Shiteno Silk no Oyo o Mezasu - Silk Tanpakushitsu no Shokuhin Kinosei o Akiraka ni suru Eiyogakuteki Kenkyu -", YASAN, vol. 55, January 2006 (2006-01-01), pages 11 - 14, XP003021991 *
ZHAORIGETU S. ET AL.: "Silk protein, sericin, suppresses DMBA-TPA-induced mouse skin tumorigenesis by reducing oxidative stress, inflammatory responses and endogenous tumor promoter TNF-alpha", ONCOLOGY REPORTS, vol. 10, no. 3, 2003, pages 537 - 543, XP008113880 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010180149A (ja) * 2009-02-04 2010-08-19 Lintec Corp 嚥下補助剤

Also Published As

Publication number Publication date
US8722614B2 (en) 2014-05-13
EP2127663A1 (en) 2009-12-02
US20100035810A1 (en) 2010-02-11
JP2010018522A (ja) 2010-01-28
EP2127663A4 (en) 2011-04-13

Similar Documents

Publication Publication Date Title
WO2008123128A1 (ja) アディポネクチン産生促進剤
TW200806194A (en) Preparation method of fermented fruits and vegetables, fermented fruits and vegetables prepared thereby and functional composition comprising the same
BR112012005768A2 (ja) An anti-overweight agent, food and drinks for anti-overweight, a glucose tolerance improvement agent, and food and drinks for a glucose tolerance improvement
WO2009103884A3 (fr) Composition pour l'alimentation humaine et/ou animale, ses utilisations, levures
CA2751227C (en) Composition from sphaeranthus indicus and garcinia mangostana for the control of metabolic syndrome
WO2008143182A1 (ja) 甘草ポリフェノールを含有する組成物
WO2010146568A3 (en) Bifidobacteria for treating diabetes and related conditions
WO2010030054A3 (en) Uses of sesquiterpene derivatives
WO2007045252A3 (en) An edible composition
WO2011106423A3 (en) Acai and iridoid based formulations
EP1920774A4 (en) COMPOSITION CONTAINING FUCOIDAN OR FUCOIDAN HYDROLYSAT AND AN IMMUNOSTIMULATING SUBSTANCE
WO2011106432A3 (en) Morinda citrifolia and iridoid based formulations
EP1949792A3 (en) The healthy and functional foods for the obesity patients using purple-colored potato
EP2014295A3 (en) Topical compositions for the prevention and treatment of inflammatory and/or infective conditions of the genital area
WO2012033378A3 (ko) 비만억제 활성과 혈당강하 효능이 있는 꾸지뽕 및 의이인을 포함하는 조성물 및 이의 용도
WO2011043631A3 (ko) 호장근 추출물, 이의 분획물 또는 스틸벤계 화합물을 포함하는 감기의 예방 및 치료용 약학 조성물
WO2013022279A3 (en) N1-cyclic amine-n5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same
WO2011095882A8 (en) Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency
WO2011025271A3 (ko) 메트포르민 아스코르브산염, 그의 제조방법, 그를 포함하는 약학 조성물 및 그를 포함하는 복합제제
WO2010041832A3 (ko) 패 유래 화합물 함유 항산화 활성 조성물
DK1708711T3 (da) Sammensætninger, der især er anvendelige til behandling eller forebyggelse af metabolisk syndrom
WO2009038095A1 (ja) セサミン類とビタミンb1類とを配合した組成物
WO2006109194A3 (en) Chromium-fatty acid compounds and methods of making and using thereof
WO2013025073A3 (ko) 유홍초 추출물을 함유하는 당뇨합병증 예방 또는 치료용 조성물
WO2008108285A1 (ja) ペプチド

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08722602

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 12450286

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2008722602

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: JP